EW

#333
Edwards Lifesciences Corp
78.59 USD
+1.08%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
77.56
78.59
Intervallo Annuale
68.63
87.89
Variazione giornaliera
+1.08%
Variazione Mensile
-4.31%
Variazione di 6 mesi
+8.04%
Variazione Annuale
+11.48%
Chiusura Precedente
77.75
Apertura
77.78
Bid
Ask
Minimo
77.56
High
78.59
Volume
163
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 45.65 B
  • Employee 16 K
  • Founded N/A
  • CEO N/A
  • Website www.edwards.com
  • Headquarter Delaware, United States
  • FIGI BBG000BRXP69
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
46.58
Rapporto prezzo/fatturato
8.26

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility completed in 2021 in Limerick, Ireland.

Notizie